Clinical Trial Update: Lovastatin: Immunomodulatory Value Evaluation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the immunomodulatory effects of lovastatin in people with HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lovastatin (Lovastatin)

Snippet

Sponsor: Universidad de Antioquia | Conditions: HIV Seropositivity | Phase 2 | Status: COMPLETED